Clinical trial
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy…
NCT00434395 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00434395 |
|---|---|
| Title | Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects |
| Official title | A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)-Controlled, 4-Period Crossover Study of the Effects of a Single Dose of MOA-728 Infused Intravenously on Cardiac Repolarization in Healthy Subjects |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | MOA-728 |
| Start date | Mar 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 13, 2007 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: